Profusa Q2 net loss $8.8M; cash $719K; progress on G3 option

Profusa, Inc.

2026-Q2 EPS reported -$326.74

Net loss Q2 2026 $(8.8)M vs $(2.2)M year-ago; six-month loss $(12.2)M vs $(5.1)M.
Cash at June 30 $719K; total assets $1.0M; stockholders' deficit $(27.1)M.
Debt/liability holders executed $10.7M Series A Convertible Exchange Agreements; $4.57M converted to preferred.
Borrowed $650K for working capital; 4:1 reverse stock split effective Aug 18, 2026.
G3 audits expected by mid-September; combined company to operate as public diagnostics with CLIA labs.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.